| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2026-04-08 16:28 Tx date 2026-04-01 |
$N/A
BRIAPRO THERAPEUTICS CORP. |
Gross, Jane
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+359,000 vol |
359,000 | |
| Filed 2026-04-08 16:27 Tx date 2026-04-01 |
$N/A
BRIAPRO THERAPEUTICS CORP. |
Gross, Jane
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+359,000 vol |
||
| Filed 2026-04-08 16:26 Tx date 2023-08-31 |
$N/A
BRIAPRO THERAPEUTICS CORP. |
Gross, Jane
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-10-02 16:21 Tx date 2025-09-30 |
$BCT
BriaCell Therapeutics Corp. |
Gross, Jane
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
46 - Compensation for services
|
+5,000 vol |
5,000 | |
| Filed 2025-10-02 16:20 Tx date 2023-06-20 |
$BCT
BriaCell Therapeutics Corp. |
Gross, Jane
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-08-27 17:23 Tx date 2025-08-25 |
$BCT
BriaCell Therapeutics Corp. |
Gross, Jane
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-6,001 vol |
666 | |
| Filed 2025-01-27 20:11 Tx date 2025-01-24 |
$BCT
BriaCell Therapeutics Corp. |
Gross, Jane
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-93,333 vol |
6,667 | |
| Filed 2025-01-27 20:10 Tx date 2023-06-20 |
$BCT
BriaCell Therapeutics Corp. |
Gross, Jane
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
100,000 |